FDA Inspection 1070525 — Oksana A. Serebrennikova, MD, PhD
The FDA completed an inspection of Oksana A. Serebrennikova, MD, PhD on Oct 18, 2018 in Vinnytsa 21018. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Oct 18, 2018
- Fiscal Year
- 2019
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Vinnytsa 21018 (Ukraine)
Additional Details
Clinical Investigator (CI)